Search Results - Milan J. Sonneveld
- Showing 1 - 17 results of 17
-
1
Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline by Milan J. Sonneveld, Vincent Rijckborst, Charles A. Boucher, Bettina E. Hansen, Harry L.A. Janssen
Published 2010Artigo -
2
-
3
Presence of precore and core promoter mutants limits the probability of response to peginterferon in hepatitis B e antigen-positive chronic hepatitis B by Milan J. Sonneveld, Vincent Rijckborst, Stefan Zeuzem, Jenny Heathcote, Krzysztof Simon, Hakan Şentürk, Suzan D. Pas, Bettina E. Hansen, Harry L.A. Janssen
Published 2012Artigo -
4
Response-guided peginterferon therapy in hepatitis B e antigen-positive chronic hepatitis B using serum hepatitis B surface antigen levels by Milan J. Sonneveld, Bettina E. Hansen, Teerha Piratvisuth, Jidong Jia, Stefan Zeuzem, Edward Gane, Yun–Fan Liaw, Qing Xie, Jenny Heathcote, Henry Lik‐Yuen Chan, Harry L.A. Janssen
Published 2013Artigo -
5
Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B by Laurens A. van Kleef, Hannah Choi, Willem Pieter Brouwer, Bettina E. Hansen, Keyur Patel, Robert A. de Man, Harry L.A. Janssen, Robert J. de Knegt, Milan J. Sonneveld
Published 2021Artigo -
6
Polymorphisms Near IL28B and Serologic Response to Peginterferon in HBeAg-Positive Patients With Chronic Hepatitis B by Milan J. Sonneveld, Vincent Wai‐Sun Wong, Andrea M. Woltman, Grace Lai‐Hung Wong, Yılmaz Çakaloğlu, Stefan Zeuzem, Erik H.C.J. Buster, André G. Uitterlinden, Bettina E. Hansen, Henry Lik‐Yuen Chan, Harry L.A. Janssen
Published 2011Artigo -
7
Metabolic Dysfunction–Associated Fibrosis 5 (MAF-5) Score Predicts Liver Fibrosis Risk and Outcome in the General Population With Metabolic Dysfunction by Laurens A. van Kleef, Sven Francque, Jhon Edison Prieto Ortíz, Milan J. Sonneveld, Carlos B Sanchez-Luque, Robin G Prieto-Ortiz, Wilhelmus J. Kwanten, Luisa Vonghia, An Verrijken, Christophe De Block, Zouhir Gadi, Harry L.A. Janssen, Robert J. de Knegt, Willem Pieter Brouwer
Published 2024Artigo -
8
The Association Between Metabolic Dysfunction‐Associated Steatotic Liver Disease and Change in Liver Stiffness in Patients With Chronic Hepatitis B by Lesley A. Patmore, Kirsi van Eekhout, Özgür M. Koc, Robert J. de Knegt, Harry L.A. Janssen, Willem Pieter Brouwer, Matthijs Kramer, Pieter Honkoop, Joep de Bruijne, Greet J. Boland, Douwe F. Postma, Hans Blokzijl, Robert A. de Man, R. Bart Takkenberg, Milan J. Sonneveld
Published 2025Artigo -
9
Hepatitis B Surface Antigen Declines and Clearance During Long-Term Tenofovir Therapy in Patients Coinfected With HBV and HIV by Roeland Zoutendijk, Hans L. Zaaijer, T.E.M.S. de Vries-Sluijs, Jurriën G.P. Reijnders, Jan W. Mulder, Frank P. Kroon, Clemens Richter, Annemiek A. van der Eijk, Milan J. Sonneveld, Bettina E. Hansen, Rob A. de Man, Marc van der Valk, Harry L.A. Janssen
Published 2012Artigo -
10
Adding pegylated interferon to entecavir for hepatitis B e antigen–positive chronic hepatitis B: A multicenter randomized trial (ARES study) by Willem Pieter Brouwer, Qing Xie, Milan J. Sonneveld, Ning‐Ping Zhang, Qin Zhang, Fehmı Tabak, Adrian Streinu‐Cercel, Jiyao Wang, Ramazan İdilman, Hendrik W. Reesink, Mircea Diculescu, Krzysztof Simon, M Voiculescu, Meral Akdoğan, Włodzimierz Mazur, Jurriën G.P. Reijnders, Elke Verhey, Bettina E. Hansen, Harry L.A. Janssen
Published 2014Artigo -
11
Association of metabolic comorbidities with fibrosis severity and fibrosis regression in patients with chronic hepatitis B by Lisa M. van Velsen, Lesley A. Patmore, Jordan J. Feld, Henry Lik‐Yuen Chan, Teerha Piratvisuth, Rong‐Nan Chien, Edo J. Dongelmans, Vedran Pavlovic, Leland J. Yee, Willem Pieter Brouwer, Audrey Lau, Bettina E. Hansen, Marı́a Buti, Qing Xie, Keyur Patel, Scott Fung, Harry L.A. Janssen, Milan J. Sonneveld
Published 2025Artigo -
12
Association Between the Presence of Metabolic Comorbidities and Liver-Related Events in Patients With Chronic Hepatitis B by Lesley A. Patmore, Warshan K. Katwaroe, Daniël P. C. van der Spek, Hannah Choi, Keyur P. Patel, Sylvia Brakenhoff, Adriaan J. van der Meer, Willem Pieter Brouwer, Laurens A. van Kleef, Robert J. de Knegt, Bettina E. Hansen, Rob A. de Man, Jordan J. Feld, Harry L.A. Janssen, Milan J. Sonneveld
Published 2023Artigo -
13
Prediction of Sustained Response After Nucleo(s)tide Analogue Cessation Using HBsAg and HBcrAg Levels: A Multicenter Study (CREATE) by Milan J. Sonneveld, Jun Yong Park, Apichat Kaewdech, Wai‐Kay Seto, Yasuhito Tanaka, Ivana Carey, Μargarita Papatheodoridi, Florian van Bömmel, Thomas Berg, Fabien Zoulim, Sang Hoon Ahn, George Ν. Dalekos, Nicole S. Erler, Christoph Höner zu Siederdissen, Heiner Wedemeyer, Markus Cornberg, Man‐Fung Yuen, Kosh Agarwal, André Boonstra, Marı́a Buti, Teerha Piratvisuth, George Papatheodoridis, Benjamin Maasoumy
Published 2020Artigo -
14
Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels by Milan J. Sonneveld, Shao‐Ming Chiu, Jun Yong Park, Sylvia M. Brakenhoff, Apichat Kaewdech, Wai‐Kay Seto, Yasuhito Tanaka, Ivana Carey, Μargarita Papatheodoridi, Florian van Bömmel, Thomas Berg, Fabien Zoulim, Sang Hoon Ahn, George Ν. Dalekos, Nicole S. Erler, Christoph Höner zu Siederdissen, Heiner Wedemeyer, Markus Cornberg, Man‐Fung Yuen, Kosh Agarwal, André Boonstra, Marı́a Buti, Teerha Piratvisuth, George Papatheodoridis, Chien‐Hung Chen, Benjamin Maasoumy
Published 2022Artigo -
15
Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study) by Grishma Hirode, Hannah Choi, Chien‐Hung Chen, Tung‐Hung Su, Wai‐Kay Seto, Stijn Van Hees, Μargarita Papatheodoridi, Sabela Lens, Grace Lai‐Hung Wong, Sylvia M. Brakenhoff, Rong‐Nan Chien, Jordan J. Feld, Milan J. Sonneveld, Henry Lik‐Yuen Chan, Xavier Forns, George Papatheodoridis, Thomas Vanwolleghem, Man‐Fung Yuen, Yao‐Chun Hsu, Jia‐Horng Kao, Markus Cornberg, Bettina E. Hansen, Wen‐Juei Jeng, Harry L.A. Janssen
Published 2021Artigo -
16
Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B S... by Grishma Hirode, Bettina E. Hansen, Chien‐Hung Chen, Tung‐Hung Su, Grace Lai‐Hung Wong, Wai‐Kay Seto, Stijn Van Hees, Μargarita Papatheodoridi, Sylvia M. Brakenhoff, Sabela Lens, Hannah Choi, Rong‐Nan Chien, Jordan J. Feld, Xavier Forns, Milan J. Sonneveld, George Papatheodoridis, Thomas Vanwolleghem, Man‐Fung Yuen, Henry Lik‐Yuen Chan, Jia‐Horng Kao, Yao‐Chun Hsu, Markus Cornberg, Wen‐Juei Jeng, Harry L.A. Janssen
Published 2023Artigo -
17
Predictors of hepatic flares after nucleos(t)ide analogue cessation - Results of a global cohort study (RETRACT-B study) by Edo J. Dongelmans, Grishma Hirode, Bettina E. Hansen, Chien‐Hung Chen, Tung‐Hung Su, Wai‐Kay Seto, Arno Furquim d’Almeida, Stijn Van Hees, Μargarita Papatheodoridi, Sabela Lens, Grace Lai‐Hung Wong, Sylvia M. Brakenhoff, Rong‐Nan Chien, Jordan J. Feld, Henry Lik‐Yuen Chan, Xavier Forns, George Papatheodoridis, Thomas Vanwolleghem, Man‐Fung Yuen, Yao‐Chun Hsu, Jia‐Horng Kao, Markus Cornberg, Milan J. Sonneveld, Wen‐Juei Jeng, Harry L.A. Janssen
Published 2024Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Gastroenterology
Virus
Immunology
Hepatitis B
HBsAg
Hepatitis B virus
Chronic hepatitis
Virology
HBeAg
Biology
Confidence interval
Gene
Antigen
Cohort
Genotype
Hazard ratio
Biochemistry
Diabetes mellitus
Disease
Endocrinology
Lamivudine
Metabolic syndrome
Obesity
Antibody
Cirrhosis
Dyslipidemia
Entecavir
Fatty liver